GNT Pharma
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Rescues On Reperfusion Damage In Cerebral Infarction by Nelonemdaz (NCT05041010) | GNT Pharma | 2021-12-25 |
| Antioxidant and NMDA Receptor Blocker Wins Anoxic Brain Damage of KorEa OHCA Patients (NCT03651557) | GNT Pharma | 2018-11-29 |
| Safety and Optimal Neuroprotection of neu2000 in Ischemic Stroke With Endovascular reCanalizion (SONIC) (NCT02831088) | GNT Pharma | 2016-07-01 |
Track GNT Pharma automatically
Every clearance here is in the API, with alerts when new ones post.